Joan Montaner. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Cerebral Hemorrhage/bloodCerebral Hemorrhage/prevention & controlCholesterol/bloodFibrinolytic Agents/therapeutic useHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic usePredictive Value of TestsStroke/bloodStroke/drug therapyThrombolytic Therapy/methodsTissue Plasminogen Activator/therapeutic useTreatment Outcome
Substances: See more » Fibrinolytic AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsCholesterolTissue Plasminogen Activator
Year: 2007 PMID: 18048844 DOI: 10.1161/STROKEAHA.107.499673
Source DB: PubMed Journal: Stroke ISSN: 0039-2499 Impact factor: 7.914